Wednesday, June 22, 2016

BRIEF-Compugen says discloses lead therapeutic candidate for CGEN-15029 immuno-oncology program

* Discloses Lead Therapeutic Candidate For Cgen-15029

immuno-oncology program

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)